Live from the NIH registry
Studies recruiting near St. Louis right now
Top 25 of 1,481 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Washington University School of Medicine- Siteman Cancer Center — St Louis, Missouri (2.6 mi)
· Sponsor: Relay Therapeutics, Inc.
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
Washington University in St. Louis — St Louis, Missouri (2.6 mi)
· Sponsor: Tr1X, Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Midwest Vision Research Foundation — Chesterfield, Missouri (18.0 mi)
· Sponsor: Genentech, Inc.
Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer
Advanced Breast Cancer
Phase 2
Interventional 24 participants sought
Research Site — St Louis, Missouri (2.6 mi)
· Sponsor: AstraZeneca
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: Astellas Pharma Inc
Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery
Spinal Fusion, Hyperglycemia
N/A
Interventional 50 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: Alexander T. Yahanda
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG
Phase 2
Interventional 60 participants sought
St. Louis Children's Hospital — St Louis, Missouri (2.6 mi)
· Sponsor: Nationwide Children's Hospital
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Town and Country, Missouri (11.9 mi)
· Sponsor: Axsome Therapeutics, Inc.
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
Hand Transplantation, Peripheral Nerve Injuries
N/A
Interventional 180 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: University of Missouri-Columbia
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
HPV-unrelated Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 81 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: Washington University School of Medicine
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL)
Phase 1
Interventional 106 participants sought
Washington University School of Medicine/Siteman Cancer Center — St Louis, Missouri (2.6 mi)
· Sponsor: Umoja Biopharma
Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma
Metastatic Soft-tissue Sarcoma
Phase 1
Interventional 18 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: Washington University School of Medicine
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction, Concentric Hypertrophy
N/A
Interventional 105 participants sought
Prairie Education and Research Cooperative-St. Elizabeth's — O'Fallon, Illinois (18.3 mi)
· Sponsor: Medtronic Cardiac Rhythm and Heart Failure
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Alzheimer Disease
Phase 4
Interventional 150 participants sought
Tekton Research Saint Louis Psychiatry — St Louis, Missouri (2.6 mi)
· Sponsor: Alpha Cognition, Inc
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
Missouri Baptist Medical Center — St Louis, Missouri (2.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy
Invasive Mould Infection
Phase 2
Interventional 60 participants sought
Washington U. — St Louis, Missouri (2.6 mi)
· Sponsor: Elion Therapeutics, Inc.
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
Barnes Jewish Hospital — St Louis, Missouri (2.6 mi)
· Sponsor: Cook Research Incorporated
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
Washington University in St. Louis — St Louis, Missouri (2.6 mi)
· Sponsor: Synairgen Research Ltd.
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Healthcare Research Network — Hazelwood, Missouri (11.6 mi)
· Sponsor: Crystalys Therapeutics
The Vanguard Study: Testing a New Way to Screen for Cancer
Bladder Carcinoma, Breast Carcinoma
N/A
Interventional 24,000 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: National Cancer Institute (NCI)
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors
Solid Tumor
Phase 2
Interventional 55 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: Emory University
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Acute Ischemic Stroke
Phase 2, Phase 3
Interventional 740 participants sought
Corxel Investigational Site — St Louis, Missouri (2.6 mi)
· Sponsor: Corxel Pharmaceuticals
Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes
Gastrointestinal Symptoms, Constipation
N/A
Interventional 30 participants sought
Lindenwood University — Saint Charles, Missouri (16.3 mi)
· Sponsor: Lindenwood University
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: National Cancer Institute (NCI)
Promoting Improved Functioning Among People Experiencing Stressful Situations
Acute Stress Reaction
N/A
Interventional 450 participants sought
Washington University, St. Louis — St Louis, Missouri (2.6 mi)
· Sponsor: University of North Carolina, Chapel Hill